Event Recap: Fifth Annual Health Solutions Summit
On November 17th, 2026, the Committee for a Responsible Federal Budget held its Fifth Annual Health Solutions Summit on Capitol Hill with over 250 guests. Every year, the Committee gathers policymakers, experts, and researchers to discuss how Congress and the Administration could lower health spending nationwide. This year included a special guest, Mark Cuban, the co-founder of Cost Plus Drugs, along with several speakers and panels who focused on Medicare, Medicaid, and health care affordability.
Watch the event here.
The event kicked off with a luncheon featuring Dr. Amol Navathe, the new chair of the Medicare Payment Advisory Commission (MedPAC). Dr. Navathe discussed some of MedPAC’s priority research topics, such as improving the accuracy of the Physician Fee Schedule, comparing Medicare Advantage payments to fee-for-service, as well as federal spending trends in Part D. Following his presentation, Anna Bonelli, Director of Health Policy at the Committee, asked key questions about how Congress might address upcoming Medicare challenges surrounding the Medicare Hospital Insurance trust fund and Medicare Part D.
Next, Marc Goldwein, Senior Vice President and Senior Policy Director, moderated a panel on “The New Congress and What it Means for Medicare and Affordability.” The panel featured Melinda Buntin of Johns Hopkins University, Jackson Hammond of Paragon Health Institute, Katie Martin of Health Care Cost Institute, and Sophia Tripoli of Families USA. The discussion focused on key policies that could help lower federal spending in the Medicare program – such as site-neutral payments and curbing Medicare Advantage overpayments – as well as improve affordability through 340B drug pricing reform and transparency.
Following the first panel, Mike Sturm, Chief Transformation Officer at the Centers for Medicare & Medicaid Services (CMS), discussed CMS’s focus on program integrity, administrative efficiency, and artificial intelligence (AI).
The Committee was delighted to welcome Mark Cuban, co-founder of Cost Plus Drugs, to a fireside chat with Committee president Maya MacGuineas. The two discussed Cuban’s founding of Cost Plus Drugs, how he decided to get into the industry, opportunities to lower costs in employer-sponsored insurance, opportunities for improvement in pharmacy benefit manager payment policy, and how AI will change the industry.
The programming concluded with the panel “Medicaid After the One Big Beautiful Bill Act,” moderated by Anna Bonelli, and featured Timothy Hill, an independent consultant, Calder Lynch of Humana, Matt Salo of Salo Health Strategies, and Tisamarie Sherry of Urban Institute. The panel explored the limitations of supplemental payments, how states will finance their programs in the coming years, and opportunities for CMS to reduce costs in the second half of the administration.
The program concluded with a networking reception that hosted health policy experts, researchers, and Congressional staff. The Committee thanks all of our distinguished speakers and all who attended the event.